Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation. This story matters for Finance & Markets readers tracking fund. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily fund signal